ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema

por Kodjikian L, Lecleire-Collet A, Dot C, Le Lez ML, Baillif S, Erginay A, Souied E, Fourmaux E, Gain P, Ponthieux A
Publicado 2021